Assembly Biosciences ASMB
NASDAQ ASMB
$21.73 +0.54 (+2.55%)
As of: Oct 21, 2026 · 10:51 AM EDT

Assembly Biosciences (ASMB) Other financing activities (2010 - 2012)

Updated

Assembly Biosciences (ASMB) posted Other financing activities of -$57,889 for Q2 2012.

Analysis

Assembly Biosciences (ASMB) Other financing activities (2010 - 2012) Analysis & Trends

For FY2010, Assembly Biosciences' Other financing activities came in at $755,092, up 887.6% from FY2009.

  • In prior years, Assembly Biosciences' Other financing activities was $76,461 in FY2009.
  • The Q2 2012 figure stands as the lowest quarterly Other financing activities since Q4 2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,132.04 Bn 1,100.62 Bn 19.71 Bn
2 Johnson & Johnson 614.86 Bn 533.39 Bn 17.26 Bn
3 AbbVie 503.32 Bn 476.44 Bn 12.70 Bn
4 Merck 367.14 Bn 321.52 Bn 12.21 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn
6 Astrazeneca 261.69 Bn 235.37 Bn 12.86 Bn
7 Amgen 236.43 Bn 191.82 Bn 7.24 Bn
8 Gilead Sciences 190.71 Bn 164.90 Bn 6.22 Bn
9 Pfizer 170.03 Bn 116.68 Bn 10.94 Bn
10 Assembly Biosciences 409.88 Mn -617.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2012 57,889.00
Mar 31, 2012 -57,889.00
Dec 31, 2010 234,657.00
Sep 30, 2010 -157,500.00
API Access

Assembly Biosciences Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ASMB&period=max&api_key=YOUR_API_KEY